Kezar Life Sciences Inc
KZR
Mkt cap
$53.86M
EV/Sales
—
P/E ratio
—
FY2025 Revenue
—
EPS (9mo ended 2025-09-30)
−$5.67
Gross Margin (FY2025)
—
Profit Margin (FY2025)
—
Beta
—
Div yield
—
Sector
Healthcare
KZR at a glance
KZR AI brief
AIOverview
What matters now, from SEC filings and analyst ratings
Takeaway
A takeaway appears here once the latest filing has been analyzed.
Analysts
RatingsQuant grade metrics
Sector-relative grades for valuation, growth, profitability, momentum and revisions
Financials
Earnings
Ownership
Insiders
Form 4 trades, last 90 days
Filings
Latest SEC filings
No recent SEC filings on file.
News
Latest stored headlines
KZR — Kezar Life Sciences Inc · $53.9M cap
KZR Key Statistics
- Market Cap: $53.9M
- P/B Ratio: 0.77
Kezar Life Sciences Inc (KZR) is a biotechnology company listed on NASDAQ.
Latest reported KZR revenue for 2025-12-31 was $0. Net income was -$56.0M. KZR currently screens at market cap $53.9M.
Use this KZR research hub for sector, financials, and filings — not a live tape.
Kezar Life Sciences Inc latest statements (FY2025)
Latest cached year on this hub. Full KZR income, balance, and cash tables.
- Net Income-$56.0M
- Total Assets$76.6M
- Free Cash Flow-$51.8M
KZR FAQ
What industry is KZR in?
Kezar Life Sciences Inc (KZR) is a biotechnology company in the Healthcare sector.
What is KZR's latest net income?
Latest cached Kezar Life Sciences Inc (KZR) net income for Dec 31, 2025 was -$56.0M. Statements: https://lician.com/financials/kzr
What is KZR's market cap?
Kezar Life Sciences Inc (KZR) market capitalization is $53.9M on the latest cached snapshot.